Green Spirit Industries Inc. Ranked in Top 25 by CannaInvestor Magazine
DORADO, Puerto Rico, June 27, 2018 (GLOBE NEWSWIRE) -- Green Spirit Industries Inc. (OTCQB:GSRX) (“Green Spirit” or the “Company”) has been ranked as a Top 25 Stock Pick by CannaInvestor Magazine, in its June/July 2018 issue (Top 25 Stock Picks).
Green Spirit is ranked #8 on the publication’s list of Top 25 Stock Picks for short-term investors. A company’s ranking is based on certain criteria including its 52-week range price, its closing price as of June 22, 2018, the number of shares outstanding, its public float, liquidity, risk of dilution, and its recent uplisting to the OTCQB Market.
“Among all the publicly traded companies in this rapidly growing industry, Green Spirit Industries Inc. stands out as a model U.S. cannabis company,” said Derwin Wallace, founder of CannaInvestor Magazine. “They have revenue-generating dispensaries currently operating in California and Puerto Rico with more on the way, and the Company is growing their business vertically through cultivation, extraction and production businesses in California. The stock is down significantly from its 52-week high and is, in fact, near its 52-week low. The Company has raised more than $8 million in the past 12 months, has no convertible debt, and its risk/reward ratio is extremely low.”
Green Spirit issued its first annual update to shareholders on June 20, 2018 (GSRX Shareholder Update), and continues to provide regular updates on the progress of its various cannabis-centric businesses.
About Green Spirit Industries Inc.
Green Spirit Industries Inc. (OTCQB:GSRX), through its subsidiaries, is in the business of acquiring, developing and operating retail cannabis dispensaries, and is in the process of expanding its business to include the cultivation, extraction, manufacture and delivery of cannabis and cannabinoid products. To date, Green Spirit has acquired and operates four cannabis dispensaries in California and Puerto Rico, and has acquired four additional pre-qualified locations in Puerto Rico, all of which are under construction with expected openings later this year. The Company expanded its California operations into the cultivation/growing, extraction/processing and cannabinoid manufacturing businesses during the first quarter of 2018 through joint ventures in which it holds majority stakes.
About CannaInvestor Magazine
CannaInvestor Magazine is a monthly subscription based digital magazine with an exclusive focus on cannabis finance that delivers convenient insights on publicly-traded and privately-held cannabis companies through informative articles, company profiles, and market trends that inform and educate investors. The magazine attracts inquisitive, highly engaged digital audiences around the globe. Subscription is free at (CannaInvestor Magazine)
Forward-Looking Statements
This press release contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development plans (including acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. Factors that could cause actual results to differ materially from such forward-looking statements include the risks described in greater detail in the following paragraphs. All forward-looking statements in this document are made as of the date hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking statement except where applicable law requires us to update these statements. Market data used throughout this prospectus is based on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal surveys, independent industry publications and other publicly available information.
Contact:
Paul Gendreau
PGPR
paul@pgprmedia.com
678-807-7945
© 2018 GlobeNewswire, Inc. All Rights Reserved.
U.S. FDA Approves Gilead Sciences' (Nasdaq: GILD) Antiviral Veklury (remdesivir) for the Treatment of COVID-19
